<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Advances in Molecular Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Advances in Molecular Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Успехи молекулярной онкологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-805X</issn><issn publication-format="electronic">2413-3787</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">33</article-id><article-id pub-id-type="doi">10.17650/2313-805X.2015.2.2.63-67</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>RESEARCH ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The features of leptin and its receptor expression in metastatic cutaneous melanoma</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности экспрессии лептина и его рецептора при метастатической меланоме кожи</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lushnikova</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Лушникова</surname><given-names>Анна Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoye Shosse, Moscow, 115478, Russia</p></bio><bio xml:lang="ru"><p>Россия, 115478, Москва, Каширское шоссе, 24</p></bio><email>LAN21@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Balbutsky</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Балбуцкий</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoye Shosse, Moscow, 115478, Russia</p></bio><bio xml:lang="ru"><p>Россия, 115478, Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ponkratova</surname><given-names>D. A.</given-names></name><name xml:lang="ru"><surname>Понкратова</surname><given-names>Д. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoye Shosse, Moscow, 115478, Russia</p></bio><bio xml:lang="ru"><p>Россия, 115478, Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kazubskaya</surname><given-names>T. P.</given-names></name><name xml:lang="ru"><surname>Казубская</surname><given-names>Т. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoye Shosse, Moscow, 115478, Russia</p></bio><bio xml:lang="ru"><p>Россия, 115478, Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N. N. Blokhin Russian Cancer Research Center</institution></aff><aff><institution xml:lang="ru">ФГБНУ «РОНЦ им. Н. Н. Блохина»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-05-15" publication-format="electronic"><day>15</day><month>05</month><year>2015</year></pub-date><volume>2</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>63</fpage><lpage>67</lpage><history><date date-type="received" iso-8601-date="2015-06-03"><day>03</day><month>06</month><year>2015</year></date><date date-type="accepted" iso-8601-date="2015-06-03"><day>03</day><month>06</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Lushnikova A.A., Balbutsky A.V., Ponkratova D.A., Kazubskaya T.P.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Лушникова А.А., Балбуцкий А.В., Понкратова Д.А., Казубская Т.П.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Lushnikova A.A., Balbutsky A.V., Ponkratova D.A., Kazubskaya T.P.</copyright-holder><copyright-holder xml:lang="ru">Лушникова А.А., Балбуцкий А.В., Понкратова Д.А., Казубская Т.П.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://umo.abvpress.ru/jour/article/view/33">https://umo.abvpress.ru/jour/article/view/33</self-uri><abstract xml:lang="en"><p/></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>metastatic cutaneous melanoma</kwd><kwd>leptin</kwd><kwd>leptin receptor</kwd><kwd>expression</kwd><kwd>signal transduction</kwd><kwd>carcinogenesis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>метастатическая меланома кожи</kwd><kwd>лептин</kwd><kwd>рецептор лептина</kwd><kwd>экспрессия</kwd><kwd>сигнальная трансдукция</kwd><kwd>канцерогенез</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Torisu-Itakura H., Lee J.H., Scheri R.P. et al. Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma. Clin Cancer Res 2007;13(11):3125–32.</mixed-citation><mixed-citation xml:lang="ru">Torisu-Itakura H., Lee J.H., Scheri R.P. et al. Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma. Clin Cancer Res 2007;13(11):3125–32.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Fan Y., Gan Y., Shen Y. еt al. Leptin signaling enchances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production. Oncotarget 2015;PMID 25948792.</mixed-citation><mixed-citation xml:lang="ru">Fan Y., Gan Y., Shen Y. еt al. Leptin signaling enchances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production. Oncotarget 2015;PMID 25948792.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Gao J., Tian J., Lv Y. et al. Leptin induces functional activation of through JAK2/ STAT3, MAPK/ERK and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci 2009;100(3):389–95.</mixed-citation><mixed-citation xml:lang="ru">Gao J., Tian J., Lv Y. et al. Leptin induces functional activation of through JAK2/ STAT3, MAPK/ERK and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci 2009;100(3):389–95.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Cirillo D., Rachiglio A.M., Montagna R. et al. Leptin signaling in breast cancer. An overview. J Cell Biochem 2008;105(4):956–64.</mixed-citation><mixed-citation xml:lang="ru">Cirillo D., Rachiglio A.M., Montagna R. et al. Leptin signaling in breast cancer. An overview. J Cell Biochem 2008;105(4):956–64.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Lawrence J.E., Cook N.J., Rovin R.A., Winn R.J. Leptin promotes glioblastoma. Review Neurol Res Int 2012;2012:870807.</mixed-citation><mixed-citation xml:lang="ru">Lawrence J.E., Cook N.J., Rovin R.A., Winn R.J. Leptin promotes glioblastoma. Review Neurol Res Int 2012;2012:870807.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Gogas H., Trakatelli M., Dessypris N. et al. Melanoma risk in assoсiation with serum leptin levels and lifestyle parameters: a case-control study. Ann Oncol 2008;19(2):384–9.</mixed-citation><mixed-citation xml:lang="ru">Gogas H., Trakatelli M., Dessypris N. et al. Melanoma risk in assoсiation with serum leptin levels and lifestyle parameters: a case-control study. Ann Oncol 2008;19(2):384–9.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Brandon E.L., Gu J.-W., Cantwell L. et al. Obesity promotes melanoma tumor growth: role of leptin. Cancer Biol Ther 2009;8(19):1871–9.</mixed-citation><mixed-citation xml:lang="ru">Brandon E.L., Gu J.-W., Cantwell L. et al. Obesity promotes melanoma tumor growth: role of leptin. Cancer Biol Ther 2009;8(19):1871–9.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Morpurgo G., Fioretti B., Catacuzzeno I. The increased incidence of malignant melanoma in obese individuals is due to impaired melanogenesis and melanocyte DNA repair. Med Hypothesis 2012;78(4):533–5.</mixed-citation><mixed-citation xml:lang="ru">Morpurgo G., Fioretti B., Catacuzzeno I. The increased incidence of malignant melanoma in obese individuals is due to impaired melanogenesis and melanocyte DNA repair. Med Hypothesis 2012;78(4):533–5.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Chi M., Chen J., Ye Y. et al. Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy. Curr Med Chem 2014;21(10):1255–67.</mixed-citation><mixed-citation xml:lang="ru">Chi M., Chen J., Ye Y. et al. Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy. Curr Med Chem 2014;21(10):1255–67.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Mizutani H., Fukushima S., Masuguchi S. et al. Serum levels of leptin receptor in patients with malignant melanoma as a new tumor marker. Exp Dermatol 2013;22(11):748–9.</mixed-citation><mixed-citation xml:lang="ru">Mizutani H., Fukushima S., Masuguchi S. et al. Serum levels of leptin receptor in patients with malignant melanoma as a new tumor marker. Exp Dermatol 2013;22(11):748–9.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Передереева Е.В., Лушникова А.А., Фрыкин А.Д., Пароконная А.А. Гормон лептин и проблемы репродукции. Злокачественные опухоли 2012;(1):35–9. [Peredereeva Е.V., Lushnikova А.А., Frykin А.D., Parokonnaya А.А. Hormone leptin and reproduction problems.</mixed-citation><mixed-citation xml:lang="ru">Передереева Е.В., Лушникова А.А., Фрыкин А.Д., Пароконная А.А. Гормон лептин и проблемы репродукции. Злокачественные опухоли 2012;(1):35–9. [Peredereeva Е.V., Lushnikova А.А., Frykin А.D., Parokonnaya А.А. Hormone leptin and reproduction problems.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><mixed-citation>Zlokachestvennye opukholi = Malignant Tumors 2012;(1):35–9. (In Russ.)].</mixed-citation></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">12. Giordano C., Vizza D., Panza S. et al. Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp 90 in breast cancer cells. Mol Oncol 2013;7(3):379–91.</mixed-citation><mixed-citation xml:lang="ru">Giordano C., Vizza D., Panza S. et al. Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp 90 in breast cancer cells. Mol Oncol 2013;7(3):379–91.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">13. Catalano S., Leggio A., Barone I. et al. A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo. J Cancer Мol Мed 2015;19(5): 1122–32.</mixed-citation><mixed-citation xml:lang="ru">Catalano S., Leggio A., Barone I. et al. A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo. J Cancer Мol Мed 2015;19(5): 1122–32.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">14. McMurphy T., Xiao R., Magee D. et al. The anti-tumor activity of neutralizing nanobody targeting leptin receptor in a mouse model for melanoma. PLoS One 2014;9(2):e89895.</mixed-citation><mixed-citation xml:lang="ru">McMurphy T., Xiao R., Magee D. et al. The anti-tumor activity of neutralizing nanobody targeting leptin receptor in a mouse model for melanoma. PLoS One 2014;9(2):e89895.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">15. Malvi P., Chaube B., Pandey V. еt al. Obesity induced rapid melanoma progression is reversed by oristat treatment and dietary intervention: role of adipokines. Mol Oncol 2015;9(3):689–703.</mixed-citation><mixed-citation xml:lang="ru">Malvi P., Chaube B., Pandey V. еt al. Obesity induced rapid melanoma progression is reversed by oristat treatment and dietary intervention: role of adipokines. Mol Oncol 2015;9(3):689–703.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">16. Blanquer-Rossello M.D., Santandreu F.M., Oliver J. et al. Leptin modulates mitochondrial function, dynamics and biogenesis in MCF-7 cells. J Cell Biochem 2015;doi 10.1002/jcb.25158.</mixed-citation><mixed-citation xml:lang="ru">Blanquer-Rossello M.D., Santandreu F.M., Oliver J. et al. Leptin modulates mitochondrial function, dynamics and biogenesis in MCF-7 cells. J Cell Biochem 2015;doi 10.1002/jcb.25158.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">17. Nepal S., Kim M.J., Hong J.T. et al. Autophagy induction by leptin contributes to suppression of apoptosis in cancer cells and xenograft model: involvement of p53/ FoxO3A axis. Oncotarget 2015;6(9): 7166–81.</mixed-citation><mixed-citation xml:lang="ru">Nepal S., Kim M.J., Hong J.T. et al. Autophagy induction by leptin contributes to suppression of apoptosis in cancer cells and xenograft model: involvement of p53/ FoxO3A axis. Oncotarget 2015;6(9): 7166–81.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">18. Еllerhorst J.A., Diwan A.H., Ulfort S.M. Promotion of melanoma growth by the metabolic hormone leptin. Oncol Rep 2010:23(4):901–7.</mixed-citation><mixed-citation xml:lang="ru">Еllerhorst J.A., Diwan A.H., Ulfort S.M. Promotion of melanoma growth by the metabolic hormone leptin. Oncol Rep 2010:23(4):901–7.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
